Stocks and Investing Stocks and Investing
Fri, December 15, 2023
Thu, December 14, 2023

Olivia Brayer Reiterated (VRTX) at Buy and Held Target at $380 on, Dec 14th, 2023


Published on 2024-10-28 08:00:26 - WOPRAI, Olivia Brayer
  Print publication without navigation


Olivia Brayer of Cantor Fitzgerald, Reiterated "Vertex Pharmaceuticals Incorporated" (VRTX) at Buy and Held Target at $380 on, Dec 14th, 2023.

Olivia has made no other calls on VRTX in the last 4 months.



There are 7 other peers that have a rating on VRTX. Out of the 7 peers that are also analyzing VRTX, 2 agree with Olivia's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Paul Matteis of "Stifel" Reiterated at Hold and Held Target at $373 on, Wednesday, November 22nd, 2023
  • Matthew Harrison of "Morgan Stanley" Maintained at Hold with Increased Target to $364 on, Wednesday, November 8th, 2023


These are the ratings of the 5 analyists that currently disagree with Olivia


  • Andrew Fein of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $397 on, Monday, December 11th, 2023
  • Gena Wang of "Barclays" Maintained at Buy with Increased Target to $415 on, Monday, December 11th, 2023
  • Evan Seigerman of "BMO Capital" Maintained at Buy with Increased Target to $415 on, Tuesday, November 7th, 2023
  • Eric Schmidt of "Cantor Fitzgerald" Reiterated at Buy and Held Target at $370 on, Tuesday, October 17th, 2023
  • Robyn Karnauskas of "Truist Securities" Reiterated at Strong Buy and Held Target at $456 on, Wednesday, October 4th, 2023
Contributing Sources